bit.bio
Synthetic biology for human health
Cambridge, United Kingdom · Founded 2016 · $41.5M raised
- Headquarters
- Cambridge, Cambridgeshire
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- bit.bio
- Total Funding
- $41.5M
- Last Round
- $41.5M Series AJul 2019
- Rounds
- 1
About
Cambridge-based biotech using opti-ox cell programming technology to produce precision human cells for drug discovery and cell therapy.
Summary
bit.bio is a Biotech company based in Cambridge, United Kingdom, founded in 2016. It has raised $41.5M in total across 1 round, most recently a $41.5M Series A round in Jul 2019.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jul 2019
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...